Sign In
Buy GSK
$51.53
+0.0200 (+0.0388%)
At Close: Aug 04, 2026
Wednesday's Agenda- Next to iron out latest figures, GSK expecting disappointing results
11:46am, Tuesday, 01'st Nov 2022
If GSK PLC (LSE:GSK, NYSE:GSK) (GSK PLC (LSE:GSK, NYSE:GSK), GSK PLC (LSE:GSK, NYSE:GSK)) hoped spinning off its consumer household arm Haleon in July would lead to an instant re-rating to a superchar
GSK share price gains momentum ahead of earnings: is it a buy?
12:38pm, Monday, 31'st Oct 2022
GlaxoSmithKline (LON: GSK) share price has made a strong rebound recently as investors buy the company's dip. The shares jumped to a high of 1,433p on Monday, which was the highest level since August
GSK's vaccine for RSV on course to be fast-tracked in Europe
05:00am, Friday, 28'th Oct 2022
GSK is on course to have its new RSV vaccine fast-tracked in Europe after the EMA validated its marketing application based in impressive results from a recent phase III trial. That study showed 83% e
GSK needs to confirm upward curve in next week's update
11:14am, Thursday, 27'th Oct 2022
If GSK hoped spinning off its consumer household arm Haleon in July would lead to an instant re-rating to a supercharged US pharma level, it must be sorely disappointed so far. Shares have barely move
GSK reports mixed outcome from meeting with US Food and Drug Administration
04:34am, Thursday, 27'th Oct 2022
GSK PLC (LSE:GSK, NYSE:GSK) has reported that a US Food and Drugs Administration (FDA) committee voted that the benefits of its drug, daprodustat outweighed risks for adult dialysis patients with ana
GSK to get boost if Zantac ruling reduces liability fears, reckons Citi
10:39am, Wednesday, 19'th Oct 2022
Citibank said it still expects the outcome of the Daubert (evidence admissibility) hearings into Zantac to be favourable to the defendants including GlaxoSmithKline and Sanofi after the initial procee
7 Quality Stocks Selling at a Discount as Q4 Kicks Off
09:21am, Wednesday, 19'th Oct 2022
I know that saying “This time could be different” is dangerous. But still, when it comes to U.S. stocks, I believe that this time could be different and that the long-awaited (by me, at least) bul
GSK's RSV Vaccine Candidate Shows High Efficacy in Older Adults
11:17am, Friday, 14'th Oct 2022
GSK's pivotal phase III AReSVi-006 study evaluating its respiratory syncytial virus (RSV) vaccine candidate in adults aged 60 years and above met its primary endpoint.
GSK shares trading with 'value disconnect', says broker
02:43am, Friday, 14'th Oct 2022
There is a “value disconnect” in GSK PLC (LSE:GSK, NYSE:GSK) shares, said broker Shore Capital, after “hugely positive” detailed data was published on results from the Phase III clinical trial
GSK Poised for Pfizer Battle in RSV Vaccine Market
07:37am, Thursday, 13'th Oct 2022
The British pharmaceutical giant said its experimental vaccine against respiratory syncytial virus sharply reduced the risk of disease in a key trial, paving the way for a contest with Pfizer Inc. in
GSK respiratory syncytial virus vaccine Phase 3 trial meets primary endpoint
03:29am, Thursday, 13'th Oct 2022
GSK PLC said Thursday that a Phase 3 trial of its respiratory syncytial virus vaccine candidate for adults aged over 60 years met its primary endpoint.
GSK hails 'truly exceptional' vaccine results
03:15am, Thursday, 13'th Oct 2022
GSK PLC (LSE:GSK, NYSE:GSK) hailed as ‘truly exceptional' the results from a phase III clinical trial of its respiratory syncytial virus (RSV) vaccine in people over 60. RSV causes cold-like symptom
GSK says key trial data shows its RSV vaccine is 'truly exceptional'
02:21am, Thursday, 13'th Oct 2022
Late-stage data unveiled on Thursday showed GSK's respiratory syncytial virus (RSV) vaccine was 82.6% effective in a keenly watched late-stage study involving older adults.
GSK's (GSK) Boostrix Gets FDA Nod for Pertussis in Newborns
12:47pm, Monday, 10'th Oct 2022
Following FDA approval, GSK's (GSK) Boostrix is the first vaccine in the United States specifically approved during pregnancy to prevent disease in young infants by vaccinating pregnant women.
FDA approves first vaccine to prevent whooping cough in newborns by giving shot to mother during pregnancy
03:56pm, Friday, 07'th Oct 2022
It is the first shot the FDA has approved for use during pregnancy to prevent a disease in young infants by immunizing their mothers.
